Medicine
Review Cycle Records
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Paper Review Records
All Paper Review Records
16 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Parietal GABA in individuals with amyotrophic lateral sclerosis and asymptomatic C9orf72 repeat expansion carriers assessed with MR spectroscopy at 7 T
Wytse van Hoek; Abram D. Nitert; Kevin van Veenhuijzen; Carrie Wismans; Harold H. G. Tan; Dennis W. J. Klomp; Jannie P. Wijnen; Leonard H. van Den Berg; Henk-Jan WestenengShow moreShow less
1. Department of Neurology, University Medical Centre Utrecht Brain Centre, Utrecht University; 2. Department of Radiology, University Medical Centre Utrecht, Utrecht UniversityShow moreShow less
Consciousness in ALS
Michael J. YoungShow moreShow less
1. Center for Neurotechnology and Neurorecovery, Department of Neurology, Mass General Hospital, Mass General Brigham Neuroscience Institute, Harvard Medical SchoolShow moreShow less
Longitudinal coagulation–fibrinolysis dynamics are associated with survival in amyotrophic lateral sclerosis: a prospective cohort study
Huixia Lin; Chunkai Li; Jun Wu; Junxiong YinShow moreShow less
1. Department of Neurology, Affiliated Nanjing Brain Hospital, Nanjing Medical University; 2. Department of Clinical Laboratory, Affiliated Nanjing Brain Hospital, Nanjing Medical UniversityShow moreShow less
End-of-life care of patients with amyotrophic lateral sclerosis and home mechanical ventilation: the national population-based DISCOVERY study
Mikaela Dalkvist; Karin Ersson; Stefan Bergström; Magnus Ekström; Össur Ingi Emilsson; Ludger Grote; Caroline Ingre; Ulf Kläppe; Staffan Lundström; Ingela Nygren; Josefin Sundh; Andreas PalmShow moreShow less
1. Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University; 2. Department of Medical Sciences, Clinical Physiology, Uppsala University; 3. Department of Women′s and Children′s Health, Physiotherapy, Uppsala University; 4. Department of Immunology, Genetics and Pathology, Uppsala University; 5. Department of Clinical Sciences, Respiratory Medicine, Allergology and Palliative Medicine, Faculty of Medicine, Lund University; 6. Faculty of Medicine, University of Iceland; 7. Department of Respiratory Medicine; 8. Centre for Sleep and Wake Disorders, Sahlgrenska Academy, Gothenburg University; 9. Sleep Disorders Centre, Department of Pulmonary Medicine, Sahlgrenska University Hospital; 10. Department of Clinical Neuroscience, Karolinska Institutet; 11. Department of Neurology, Karolinska University Hospital; 12. Department of Research and Development, Stockholms Sjukhem Foundation; 13. Department of Oncology-Pathology, Karolinska Institutet; 14. Department of Medical Sciences, Neurology, Uppsala University; 15. Department of Respiratory Medicine, Faculty of Medicine and Health, Örebro UniversityShow moreShow less
Factors associated with post-tracheostomy survival in Amyotrophic Lateral Sclerosis
Alessandra Maccabeo; Sara Cabras; Stefano Callegaro; Maria Ida Pateri; Francesca Pili; Antonio Canosa; Umberto Manera; Francesca Palumbo; Enrico Matteoni; Giorgio Pellegrino; Emilio Minerva; Alessandro Ciravegna; Giulia Gianferrari; Monica Puligheddu; Cristina Moglia; Fabiola De Marchi; Letizia Mazzini; Jessica Mandrioli; Giuseppe Borghero; Adriano Chiò; Andrea Calvo; Rosario VastaShow moreShow less
1. Rita Levi Montalcini’ Department of Neuroscience, University of Turin; 2. International School of Advanced Studies, University of Camerino; 3. Neurology Unit, University Hospital of Cagliari; 4. Neurology Unit 1U, “City of Health and Science” University Hospital; 5. Institute of Cognitive Science and Technologies, National Research Council; 6. Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia; 7. Department of Medical Sciences and Public Health, University of Cagliari; 8. ALS Center, “Maggiore della Carità” University Hospital, University of Piemonte Orientale; 9. Neurology Unit Department of Neurosciences Azienda Ospedaliero Universitaria di ModenaShow moreShow less
Interventions to support informal carers managing behavioral symptoms in frontotemporal lobar degeneration: a scoping review
Ana Paula Trucco; Julieta Camino; Jennifer Bedford; Eneida MioshiShow moreShow less
1. School of Health Sciences, University of East Anglia; 2. Motor Neurone Disease AssociationShow moreShow less
FAQ
How long does Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration take to review a manuscript?
As of 2026-11-19, CrushSCI has 16 complete review records for Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. The fastest paper went from submission to acceptance in 22 days (Tofersen treatment in SOD1 p.Leu145Phe ALS: real-world outcomes in a genetically homogeneous Croatian cohort, received 2026-02-01, accepted 2026-02-23); the slowest took 137 days. The average is 79 days and the median is 84.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.